The degree to which cKit-expressing progenitors generate cardiomyocytes in the heart is controversial. Genetic fate-mapping studies suggest minimal contribution; however, whether or not minimal contribution reflects minimal cardiomyogenic capacity is unclear because the embryonic origin and role in cardiogenesis of these progenitors remain elusive. Using high-resolution genetic fate-mapping approaches with cKit CreERT2/+ -induced pluripotent stem cells, we show that, paradoxically, the cardiogenic fate of CNC kit is regulated by bone morphogenetic protein antagonism, a signaling pathway activated transiently during establishment of the cardiac crescent, and extinguished from the heart before CNC invasion. Together, these findings elucidate the origin of cKit + cardiac progenitors and suggest that a nonpermissive cardiac milieu, rather than minimal cardiomyogenic capacity, controls the degree of CNC kit contribution to myocardium. 
The degree to which cKit-expressing progenitors generate cardiomyocytes in the heart is controversial. Genetic fate-mapping studies suggest minimal contribution; however, whether or not minimal contribution reflects minimal cardiomyogenic capacity is unclear because the embryonic origin and role in cardiogenesis of these progenitors remain elusive. Using high-resolution genetic fate-mapping approaches with cKit CreERT2/+ and Wnt1::Flpe mouse lines, we show that cKit delineates cardiac neural crest progenitors (CNC kit ). CNC kit possess full cardiomyogenic capacity and contribute to all CNC derivatives, including cardiac conduction system cells. Furthermore, by modeling cardiogenesis in cKit
CreERT2
-induced pluripotent stem cells, we show that, paradoxically, the cardiogenic fate of CNC kit is regulated by bone morphogenetic protein antagonism, a signaling pathway activated transiently during establishment of the cardiac crescent, and extinguished from the heart before CNC invasion. Together, these findings elucidate the origin of cKit + cardiac progenitors and suggest that a nonpermissive cardiac milieu, rather than minimal cardiomyogenic capacity, controls the degree of CNC kit contribution to myocardium.
cardiac stem cells | cardiac neural crest | cardiomyogenesis | BMP signalling H eart development is a highly regulated process during which cell lineage diversification and growth programs are dynamically coordinated in temporal and spatial manners (1) . These programs are activated sequentially, in parallel, or intersect to give rise to distinct heart domains. For example, the myocardial lineage originally develops from cardiac progenitors (CPs) of mesodermal origin (2) (3) (4) (5) , which form the first and second heart fields. However, later during morphogenesis, the cardiomyogenic program diverges and activates cardiomyocyte proliferation signals, along with CPs from the hemogenic endothelium, epicardial, cardiopulmonary, and cardiac neural crest (CNC) lineages, to produce new cardiomyocytes (1, (6) (7) (8) (9) (10) (11) . Gauging the relative contribution of each lineage for scaling their cardiomyogenic-and consequently therapeutic-capacity is a challenge. For example, many of the CP lineages are heterogeneous and incompletely characterized, and therefore cannot always be traced under a straightforward genetic fate-mapping experiment. Furthermore, it is unknown whether and how changes in the cardiac milieu (i.e., morphogens, tissue composition, and size) regulate the final proportions of heart muscle derived from each lineage.
cKit is a receptor tyrosine kinase that marks several cell lineages, including neural crest (NC), hematopoietic, and germ-line stem cells (12) (13) (14) (15) . Following the seminal description by Beltrami et al. (16) of clusters of cKit cells in the postnatal mammalian heart, several laboratories, including ours, suggested that cKit marks CPs (16) (17) (18) (19) , a finding that led to the clinical testing of these cells for heart repair (20) . Recently, a straightforward genetic fate-mapping study showed that a relatively small proportion of murine myocardium is derived from cKit + CPs, leading to the conclusion that the cardiomyogenic capacity of cKit + CPs is functionally insignificant (21) . However, the identity of cKit + CPs and the mechanisms controlling their differentiation into cardiomyocytes remain controversial (22) . Here, by using a high-resolution genetic lineage-tracing strategy, as well as induced pluripotent stem cell (iPSC)-based models of cardiogenesis, we demonstrate that cKit marks CNCs. Furthermore, we show that their relatively small contribution to myocardium during embryogenesis is not related to poor cardiomyogenic capacity, but rather to changes in the cardiac activity of the bone morphogenetic protein (BMP) pathway that prevent their differentiation into cardiomyocytes.
Results
Genetic Lineage-Tracing of cKit + CPs. We used a well-characterized cKit CreERT2/+ mouse line to lineage-trace cKit + CPs (23) (24) (25) . cKit CreERT2/+ are healthy, fertile, and express the white spotting phenotype (12, 23, 24, 26) (Fig. 1A) .
We first investigated whether cKit marks mesodermal CPs (e.g., first-or second-heart field CPs; or primitive hemogenic lineage) (1), by administering pregnant mice carrying cKit
CreERT2
;IRG embryos with tamoxifen (TAM) from embryonic days (E)7.5 to E8.5 ( Fig. 1B and Table S1 ). At E18.5, EGFP expression was detected in mesodermal cells (13, 14, 21, 26) , including gonads, blood, and lungs ( Fig. 1 C and D) . At this stage of labeling (21) , EGFP was rarely detected in the heart, and EGFP + heart cells were noncardiomyocytes with rare colocalization with the cardiac transcription factor Gata4 ( Fig. 1 E and F) .
Next, to test whether cKit marks other cardiomyogenic lineages (e.g., proliferating cardiomyocytes; or CPs of the epicardial, CNC, and definitive hemogenic lineages) (1), we administered TAM to pregnant mice at selected time points during E9.5-E12.5
Significance A high-resolution genetic lineage-tracing study in mice reveals that cKit identifies multipotent progenitors of cardiac neural crest (CNC) origin. Normally, the proportion of cardiomyocytes produced from this lineage is limited, not because of poor differentiation capacity as previously thought, but because of stage-specific changes in the activity of the bone morphogenetic protein pathway. Transient bone morphogenetic protein antagonism efficiently directs mouse iPSCs toward the CNC lineage and, consequently, the generation of cKit + CNCs with full capacity to form cardiomyocytes and other CNC derivatives in vitro. These findings resolve a long-standing controversy regarding the role of cKit in the heart, and are expected to lead to the development of novel stem cell-based therapies for the prevention and treatment of cardiovascular disease.
( Table S1 ). Cre-mediated recombination resulted in EGFP expression in embryonic melanoblasts, craniofacial cells (27) , neural tube (NT), dorsal root ganglia (DRGs), blood, gastrointestinal cells, gonads, and pulmonary cells ( Fig. 1 G-J) . Unlike the fate-map of E7.5-E8.5 cKit-expressing cells, EGFP epifluorescence is detected within the cardiac outflow tract (OFT), epicardium, and myocardium ( Fig. 1 G-J) .
To rule out a limited transgene expression, we also performed fate-mapping using the R26 promoter-driven R26R lacZ allele. The results were similar using this reporter compared with EGFP ( Fig.  1 K-N) .
To identify the original population of CPs, we administered TAM at selected time points between E9.5 and E13.5, and collected embryos 24 h after the last injection (Fig. S1A ). Using live epifluorescence and immunofluorescence (IF) imaging, we detected Cre-recombined cells in the NT, skin, lungs, gut, conotruncus, OFT, and epicardium, but not within the myocardium (Fig. S1 ). These findings suggest that the cKit CreERT2/+ -labeled heart cells during the period of TAM-induced recombination do not arise within the myocardium [i.e., differentiated cardiomyocytes (28) or transdifferentiating cardiac fibroblasts (29) and hemogenic progenitors (6, 7)], and derived from an extracardiac CP lineage.
Finally, similar to cKit CreERT2/+ reporters, cKit IF in cKit
embryos marked cells within the NT, skin, lung, OFT, and epicardium, but not differentiated cardiomyocytes (Fig. S2) . Collectively, our findings suggest that cKit marks a CP lineage that emerges at ∼E9.5 and contributes to the development of the mouse heart.
Intersectional Genetic Fate-Mapping of cKit and Wnt1 Protooncogenes.
Because our findings are consistent with a CNC origin of cKit + CPs, we used a well-established CNC-specific mouse, the Wnt1-Cre; RC::tdTomato (30) (31) (32) , to examine the expression of cKit in CNC CPs (8, 10, 11, 31-33). IF against cKit illustrated its colocalization with tdTomato in various NC-derived tissues of E12.5 Wnt1-Cre;RC:: tdTomato embryos, including the NT and the heart, ( We therefore performed NC lineage-restricted genetic fatemapping of cKit. We generated a novel mouse carrying two recombinase systems (Cre-loxP and Flp-FRT), which enables intersectional genetic fate-mapping of cKit CreERT2/+ in the Wnt1-expressing CNC lineage and its derivatives (34) . Two previously established dual-recombinase responsive indicator alleles, the RC::Fela (35) and RC::Frepe (36), and a novel Wnt1-Flpe recombinase driver line, the Wnt1::Flpe4351, were used ( Fig. 2A) .
Timed-pregnant cKit
;Wnt1::Flpe;RC::Fela or cKit CreERT2 ; Wnt1::Flpe;RC::Frepe mice were administered TAM during E8.5-E11.5 and embryo analysis was performed at selected time points between E10.5 and E18.5 (Table S1 ). Wnt1::Flpe-mediated recombination resulted in extensive labeling with the flp indicators in the craniofacial region, melanoblasts, gut, DRG, OFT, as well as in cells within the epicardium and myocardium ( Fig. 2 and Fig. S4 ). When both Wnt1::Flpe and cKit CreERT2/+ were expressed, Flpe indicators persisted in all NC-derived tissues, including the DRG, skin, heart, and OFT ( Fig. 2 and Fig. S4 A-E). However, expression of intersectional indicators was also detected in the craniofacial region, melanocytes, DRG, OFT, as well as in cells within the epicardium and myocardium ( Fig. 2 and Fig. S4 ). Importantly, expression of intersectional indicators in the lung was not documented (Fig. 2N) , consistent with the hypothesis that the heart and lung cKit + progenitors are of different origins. These studies illustrate a lineal relationship between the cKit + CPs and Wnt1
CNC kit Derivatives in the Heart. Expression of Cre-reporters was detected in all expected cardiac NC derivatives (37) , including the OFT (Figs. 1J and 3 A and B , and Figs. S2B and S5), the tunica media of the aortic arch (Fig. 3C ), cardiac and aortic valves (Fig. 3 D and E) , atria (Fig. 1K) , inflow tract, satellite glial progenitors, and sensory cells (Fig. S5 A and B and Movie S1). Consistent with their CNC origin (38) , CNC kit contributed to endothelium and smooth muscle layers of the OFT (Fig. 3 A and  B) , although coronary vascular cell differentiation was not observed (Fig. 3F) .
In agreement with previous reports in zebrafish (8, 11 ) and mice (10, 21, (31) (32) (33) , our analysis with the Wnt1-Cre (Fig. S6 and Movie S2) and cKit CreERT2/+ alleles suggests that CNCs contribute to the myocardial lineage. Particularly, we documented contribution of CNC kit to atrial and ventricular cardiomyocytes (29.9% ± 3.1% of total EGFP + derivatives) ( Fig. 3 K and L) , and pericardial, endocardial, and epicardial cells (Figs. 1 I, J, and N To better characterize the identity of CNC Kit , we studied the expression of micropthalmia-associated transcription factor (Mitf), a direct target and transactivator of cKit signaling, expressed not only in cranial NC derivatives and mast cells but also in cardiomyocytes (39) . IF analysis demonstrated that Mitf is also expressed in CNC kit and their cardiomyocytic derivatives (Fig. S7 A-C) . However, EGFP + cells in the heart did not express the melanocyte-specific markers tyrosinase or trp1, suggesting that Mitf + CNC kit derivatives in the heart are not melanocytes (Fig. S7C) .
Next, we investigated the expression of Isl1, a homeobox transcription factor that specifies the majority of the mammalian CP lineages, including CNCs (36). Accordingly, cKit
CreERT2 ;IRG mice were crossed with mice carrying an Isl1 nuclear lacZ (Isl1 nLacZ ) allele (40) . When pregnant mice were administered TAM from E9.5-E11.5, (Table S1 ), colocalization of EGFP and nLacZ was documented in cells of the NT, DRGs, and the OFT (Fig. S7 D-J To determine the full cardiomyogenic capacity of cKit + CPCs (Fig. 1) , we established iPSCs from cKit CreERT2 ;IRG mice (iPSC kit ). We induced cardiomyogenesis in iPSCs with either ascorbic acid (AA), which drives cardiogenesis partly via an intermediate differentiation stage into cKit + /Nkx2.5 + CPs (15, 41), or BMP antagonism, a signaling pathway that regulates the development of both mesodermal and NC lineages (Fig. 4A) (2, 5, 31, (42) (43) (44) (45) (46) .
Both AA or BMP antagonists enhanced cardiac differentiation into spontaneously contracting embryoid bodies (EBs) compared with controls ( Fig. 4B ) (P = 0.0073). When EBs were treated with 4-OH TAM during differentiation (Fig. 4A) , we detected that 79.05% ± 4.9% of the beating EBs generated via transient BMP antagonism were EGFP + , compared with 39.03% ± 7.7% and 43.14% ± 6.9% EGFP + beating EBs following treatment with AA or vehicle, respectively (Fig. 4 B-E and Movie S4) (P < 0.0001), suggesting that endogenous BMP signaling may limit cardiomyogenesis from cKit + CPs. Compared with control, AA, and Noggin (NOG)-treated iPSC kit , Dorsomorphin (Dorso) enhanced cardiomyogenesis by significantly repressing Brachyury transcription (Fig. 4F and Fig. S8 ), while up-regulating ISL1, NKX2-5 ( Fig. 4F) (43) . In addition, we detected a significant up-regulation in CNC-related genes, including PAX3 and WNT1 (Fig. 4G and Fig. S8 E-H) , whereas the expression of the proepicardial genes WT1, TCF21, and TBX18 (2), as well as the coronary endothelium marker KDR (Fig. 4G and 
L). (M and T) X-gal
+ CNC kit derivatives in the OFT (M and G), heart (N, O, R, and S), and epicardium (P and T) of E17.5 Wnt1::Flpe;cKit CreERT2 ;RC::Fela embryos. Arrows in M-P are depicted in higher magnification in panels Q-T, respectively. Panels B, E are photomerged image tiles. OFT, outflow tract; Ht, heart; Lu, lung. (Scale bars, 50 μm in M-P and 300px in I-L.) (Magnification, 100× in B-H and Q-T.) Fig. S8 ), were significantly down-regulated compared with controls. Finally, expression of cKit increased significantly over time (Fig.  S8D) , although the level of expression was similar between the different treatment groups (Fig. 4G) . As previously shown (15, 41) , IF analysis confirmed that myocardial specification of cKit + CPs commenced via coexpression of NKX2.5 ( Fig. 5 and Fig. S9 A-D) . Remarkably, BMP antagonism enhanced the development of EGFP + /NKX2.5 + progenitors by ∼sevenfold (Fig. 5, Fig. S9 A-D, and Movie S5) (P = 0.0057). Moreover, iPSC kit -derived CNC kit gave rise to all CNC derivatives, including EGFP + smooth muscle cells (Fig. S9 E and F) , Isl1 + (Fig. S9 G and H) , and Pax3 + CPs (Fig. S9 I and J) , while innervating the beating EBs with neurofilament-M + and Tuj1 + neurons (Fig. S9 K-N) .
Discussion
The major findings are that cKit marks CPs of CNC origin, which enter the embryonic mouse heart at ∼E9.5 and contribute a relatively small proportion of myocardium and other derivatives of the CNC, but not coronary vascular cells. In addition, we show that CNC kit CPs with cardiomyocyte differentiation capacity can be derived in vitro from mouse iPSCs following transient antagonism of the BMP pathway, which drives the stage-specific differentiation of iPSCs toward the cardiac mesodermal and CNC lineages.
Our findings confirm previous developmental studies in mice showing that, during gastrulation, cKit is expressed in extraembryonic mesoderm and embryonic ectoderm, but not mesodermal CPs (4, 13, 14, 42) . Furthermore, the findings are in agreement with previous reports supporting the existence of cKit + CPs, which do not contribute to coronary endothelium (15) , as well as with recent endothelial lineage fate-mapping analyses suggesting that the coronary endothelium is unlikely to originate from cKit + cells (6, 29) .
Notably, although much controversy exists over the contribution of CNCs to the myocardium (8, 10, 11, (30) (31) (32) (33) , our studies with the cKit CreERT2/+ , Wnt1-Cre, and Wnt1::Flpe alleles strongly support the hypothesis that the mammalian CNC holds full cardiomyogenic capacity, which our findings now suggest is undermined by developmental changes in the activity of BMP and Wnt pathways preceding their invasion in the heart (5, 31, 45) . It is also noteworthy that a pool of multipotent postmigratory NC progenitors (47, 48) , some of which express cKit (49) , has been recorded in other tissues; hence, it would be interesting to examine their relationship to CNC kit . Our study differs from a recent cardiac genetic fate-map of cKit, using different cKit alleles (21) . First, in contrast to findings presented here and elsewhere (6, 15, 29) , van Berlo et al. (21) reported that cKit CPs contribute extensively to coronary endothelium. However, it is noteworthy that mutations in the mouse W/cKit locus have not been associated with tangible cardiovascular defects (12), as would be likely if cKit + CPs comprised a major source of coronary vascular cells. Second, van Berlo et al. (21) concluded that the minimal cardiomyocyte contribution of cKit CPs reflects minimal differentiation capacity. However, although our study agrees that the in vivo cardiomyocyte contribution of cKit + CPs is lower than expected from previous reports (50, 51), we show that this is not a result of minimal differentiation capacity, but rather, because of their developmental origin in the CNC, which comprises a minor contributor of cardiomyocytes to the mammalian heart. Importantly, using iPSC modeling we demonstrate that differentiation of CNC kit to cardiomyocytes requires the BMP signaling pathway, which also directs differentiation of mesodermal CPs to the myocardium. This finding suggests that, although CNC kit hold full cardiomyocyte differentiation capacity, their in vivo contribution is repressed by spatiotemporal changes in BMP activity, which render the cardiac milieu nonconducive for cardiomyocyte differentiation during CNC invasion to the heart (45).
Our findings have several important implications. First, they resolve the current controversy over the existence and cardiomyogenic capacity of cKit + CPs (22) . We show that cKit + CPs invested within the developing heart are fully capable of producing new cardiomyocytes, both in vivo and in vitro. Therefore, coupled with the findings from many laboratories that cKit + CPs are present in the postnatal heart, they represent an important therapeutic target for heart regeneration (17-19, 52, 53) . For example, the activity of BMP in the damaged myocardium could be modulated pharmacologically, or via transplantation of cells capable of regulating BMP activity, to support production of myocardium from endogenous or exogenously supplied cKit + CPs (18, 52) .
Second, the findings advance our understanding of the cellular and molecular mechanisms underlying mammalian cardiomyogenesis, by illustrating a previously unknown relationship between the spatiotemporal modulation of the BMP pathway and the generation of myocardium from mesodermal and CNC CPs. Third, the generation of CNCs from iPSCs provides a unique opportunity to study and understand the biology and function of CNCs, as well as to test their regenerative capacity in novel cellbased therapeutic strategies. Finally, considering the technical limitations often associated with conditional gene-targeting approaches, our findings do not exclude the possibility that, in addition to CNC kit , the adult heart contains other cKit + cells with full cardiovascular differentiation capacity, as those reported by others (21, 28, 50, 51) , which may have remained undetectable with our reagents.
In conclusion, our findings support the hypothesis that the mammalian heart is invested with a cKit + CP lineage, with full capacity to generate cardiomyocytes in vivo and in vitro, and therefore provide an important therapeutic target for the prevention and treatment of heart disease. Modulation of the activity of the BMP pathway in the heart may enhance the therapeutic regeneration of damaged myocardium from CNC kit .
Materials and Methods
All animals were maintained in an Association for Assessment and Accreditation of Laboratory Animal Care-approved animal facility at the University of Miami, Miller School of Medicine, and procedures were performed using Institutional Animal Care and Use Committee-approved protocols according to NIH standards. cKit CreERT2/+ mice were developed as previously described (24) . The Wnt1-Cre, RC::tdTomato, IRG, and R26R
LacZ mouse lines were purchased from Jackson Laboratories. The Isl1 nLacZ mice have been described elsewhere (40) . Wnt1::Flpe, RC::Fela and RC::Frepe mice were developed as previously described (35, 36) . iPSC kit were generated from adult cKit CreERT2 /IRG tail-tip fibroblasts. Genotyping, TAM injections, gene-expression analysis, lineage-tracing, and histological analysis of mouse embryos was performed as previously described (24) . See SI Materials and Methods for more detailed discussion.
